Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Randomized Study to Evaluate the Bioequivalence of Selpercatinib Formulations

NCT05089019 is registered in ClinicalTrials.gov with Loxo Oncology, Inc. as lead sponsor.

NCT NCT05089019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05089019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Randomized Study to Evaluate the Bioequivalence of Selpercatinib Formulations
Lead sponsor
Loxo Oncology, Inc.
Phase
Phase 1
Overall status
Completed
Start date
October 29, 2021
Completion date
July 19, 2022
Enrollment
224 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

healthy